IS VACCINE EFFECTIVE AGAINST DELTA VIRUS, AND HOW EFFECTIVE IS IT?

Reading time is 1 mins

.
.
IS THE BIONTECH VACCINE EFFECTIVE AGAINST THE DELTA VIRUS?

How effective vaccines against the Delta variant were determined by a study conducted in the UK. The Delta variant of the BioNTech vaccine is said to have 88 percent protection. The single-dose BioNTech vaccine provides limited protection against the Delta variant of Covid-19, officials said.

A study conducted in the UK showed how effective the Pfizer/BioNTech vaccine is against the Delta variant. Details of the review, which was attended by more than 19,000 people and was one of the largest comprehensive surveys conducted in the UK, were shared with the public. The research, published in the respected and peer-reviewed medical journal The New England Journal of Medicine, revealed the effect of the Pfizer/BioNTech vaccine against the Delta variant.

.
IS SINGLE DOSE BIONTECH VACCINE INSUFFICIENT?

Officials said the single-dose Pfizer/BioNTech vaccine provides protection against the Delta variant, but it is very limited. In the study, it was noted that those who received a single dose of the Pfizer/BioNTech vaccine provided 30 percent protection against the Delta variant that showed symptoms. This rate is low, and people should definitely have two doses of the vaccine, and officials said that after the second dose, there is a very serious protection against the Delta variant that shows symptoms.

.
BIONTECH VACCINE AGAINST DELTA VIRUS PROTECTS 88 PERCENT

“The single-dose Pfizer/BioNTech vaccine provides limited protection against the Delta variant of Covid-19,” officials said. But after the second dose, protection is provided against the Delta variant, which shows symptoms,” he said. In the study, those who received the second dose of Pfizer/BioNTech vaccine had 88 percent protection against the Delta variant.

“Among those who have been vaccinated, the number of those infected with the Delta variant is also increasing,” said a US-based media outlet, writing an extensive article about this research and the Delta variant . But in these people, the disease is milder and symptoms such as headache, runny nose and sore throat appear,” he said.

“The combination of mask use and vaccine could provide serious protection against the Delta variant,” the scientists told.

.
.
.
.

Follow me
President of Organ Transplant Center at MedicalPark Hospital Antalya

Turkey's world-renowned organ transplant specialist. Dr. Demirbaş has 104 international publications and 102 national publications.

Physician's Resume:

Born on August 7, 1963 in Çorum, Prof. Dr. Alper Demirbaş has been continuing his work as the President of MedicalPark Antalya Hospital Organ Transplantation Center since 2008.

Prof. who performed the first tissue incompatible kidney transplant in Turkey, the first blood type incompatible kidney transplant, the first kidney-pancreas transplant program and the first cadaveric donor and live donor liver transplant in Antalya. Dr. As of August 2016, Alper Demirbaş has performed 4900 kidney transplants, 500 liver transplants and 95 pancreas transplants.

In addition to being the chairman of 6 national congresses, he has also been an invited speaker at 12 international and 65 national scientific congresses. Dr. Alper Demirbaş was married and the father of 1 girl and 1 boy.

Awards:

Eczacibasi Medical Award of 2002, Akdeniz University Service Award of 2005, Izder Medical Man of the Year Award of 2006, BÖHAK Medical Man of the Year Award of 2007, Sabah Mediterranean Newspaper Scientist of the Year Award of 2007, ANTIKAD Scientist of the Year Award of 2009, Social Ethics Association Award of 2010, Işık University Medical Man of the Year Award of 2015, VTV Antalya's Brand Value Award of 2015.

Certificates:

Doctor of Medicine Degree Hacettepe University Faculty of Medicine Ankara, General Surgeon Ministry of Health Turkey EKFMG (0-477-343-8), University of Miami School of Medicine Member of Multiple Organ Transplant, ASTS Multiorgan Transplant Scholarship. Lecturer at Kyoto University. Lecturer at University of Essen, Research assistant at the University of Cambridge .

Professional Members:

American Society of Transplant Surgeons, American Transplantation Society Nominated, Middle East and Southern Africa Council Transplantation Society 2007, International Liver Transplantation Association, Turkish Transplantation Association, Turkish Society of Surgery, Turkish Hepatobiliary Surgery Association.

Disclaimer:

Our website contents consist of articles approved by our Web and Medical Editorial Board with the contributions of our physicians. Our contents are prepared only for informational purposes for public benefit. Be sure to consult your doctor for diagnosis and treatment.
Medically Reviewed by Professor Doctor Alper Demirbaş
Follow me